Results 201 to 210 of about 2,544,276 (249)

Prenatal valproic acid exposure alters striatal proteomic signatures associated with autism spectrum disorder in mice. [PDF]

Transl Psychiatry
Jo EH, Choi Y, Kim HB, Woo RS, Han D, Kim WC, Park SJ, Kang M, Choi Y, Kang KW, Kim HS.   +10 more
europepmc   +1 more source

Volumetric Microsampling for Patient‐Centric Therapeutic Drug Monitoring in Clinical Pharmacology: A Scoping Review

The Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.
Abstract Accurate drug concentration measurement is essential for precision pharmacotherapy, but conventional therapeutic drug monitoring (TDM) requires venous sampling, increasing patient burden, and potentially limiting participation in TDM and model‐informed precision dosing (MIPD).
Hari Prabhath Tummala, Abbie D. Leino, Nathaniel J. Rhodes, Kevin J. Downes, Marc H. Scheetz, Manjunath P. Pai   +5 more
wiley   +1 more source

Correction to "Computational Studies of Satureja hortensis Phytochemicals as Inhibitors of AP-1 (FOS/JUN) Activation in Valproic Acid Teratogenicity". [PDF]

Birth Defects Res
europepmc   +1 more source

Exploring viscosity sensitivity of π-extended coumarin fluorogen-based PRPGs for precise photorelease of valproic acid: detection and defibrillation of TDP-43 aggregation. [PDF]

Chem Sci
Pal S, Das S, Biswas S, Murugan SD, Jana NR, Chattopadhyay AP, Singh NDP.   +6 more
europepmc   +1 more source

Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase

Journal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
ABSTRACT Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by a deficiency of aspartylglucosaminidase (AGA), a hydrolase involved in the degradation of N‐glycosylated proteins. Currently, no approved therapies are available for AGU. Development of enzyme replacement therapy (ERT) for AGU has been hampered by the complex proteolytic ...
Antje Banning, Lidia Reznikova, Adla Murad, Ritva Tikkanen   +3 more
wiley   +1 more source

Baicalin and valproic acid synergistically induce hepatocellular carcinoma cell apoptosis via ROS-mediated PTEN upregulation. [PDF]

Front Immunol
Ni Z, Jiang X, Zhou Y, Yu Y, Hou J, Wei H, Li J.   +6 more
europepmc   +1 more source

Neurocardiology: Brain–Heart Interactions in the Heart

MedComm, Volume 7, Issue 9, September 2026.
The heart and brain maintain systemic homeostasis through bidirectional communication involving neural, biochemical, and mechanical pathways. Dysregulation of these pathways contributes to a spectrum of conditions involving heart–brain interactions, including Takotsubo syndrome, the epileptic heart, stroke–heart syndrome, heart failure, cardiac ...
Wentao Wang, Hao Jia, Han Han, Jiangping Song   +3 more
wiley   +1 more source

Valproic Acid-Induced Pancreatitis in a Pediatric Patient With 17q12 Duplication Syndrome. [PDF]

Cureus
Maitah YM, Snyder AJ, Maguire I, Wu L, Aabo M.   +4 more
europepmc   +1 more source

Epilepsy‐Related Psychosis in Drug‐Resistant Epilepsy With Nonconvulsive Status Epilepticus and Difficult Antipsychotic Titration: A Case Report

Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Electroclinical findings supported diazepam‐responsive nonconvulsive status epilepticus (NCSE) in an older patient with drug‐resistant epilepsy and psychosis. After phenytoin treatment, continuous EEG helped monitor recurrence. Later symptoms were most consistent with interictal psychosis with a possible alternative psychosis component, emphasizing ...
Wataru Omori, Ryo Hirabayashi, Kenichi Oga, Yoshikazu Masuda, Go Okada   +4 more
wiley   +1 more source